Access Biotechnology
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio2 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Draig Therapeutics
9Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Draig Therapeutics | Biotech | Active | — | — |
| F2G | Biotech | Active | — | — |
| Hemab Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#160
Raises, 12 months#88
Co-investors#165
Co-investors
- Canaan PartnersVenture capital2 shared
- Sanofi VenturesVenture capital2 shared
- SR OneVenture capital2 shared
- SV Health InvestorsVenture capital2 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Deep Track CapitalVenture capital1 shared
- Novo HoldingsVenture capital1 shared
- RA CapitalVenture capital1 shared
- Sofinnova PartnersVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.